Business Performance Review

Quality-focused, compliant manufacturing & R&D infrastructure Manufacturing Infrastructure R&D Infrastructure Location Annual Installed Capacity (Jun-23) Last USFDA Inspection Date Ankleshwar, Gujarat 742.2 KL* July 2019 Approvals USFDA, MHRA (UK), FIMEA (Finland), Romania (Europe) PMDA (Japan), COFEPRIS (Mexico), Health Canada, KFDA (South Korea), Gujarat FDCA Dahej, Gujarat 381.9 KL Oct 2018 USFDA, EDQM (Europe), PMDA (Japan), KFDA (South Korea) Mohol, Maharashtra 49.1 KL March 2018 USFDA, Maharashtra FDA Kurkumbh, Maharashtra 24.6 KL -NA- Maharashtra FDA Mahape, Navi Mumbai ■ R&D for new product ■ development and complex molecules High-end analytical equipment for characterization Ankleshwar, Gujarat ■ Cost improvement programs and process improvements ☐ Dahej, Gujarat Oncology R&D ■ Cost improvement programs and process improvements * Additional 208KL will be further added to the capacity in FY24 at Ankleshwar, Gujarat. 15 Є Glenmark LIFE SCIENCES

View entire presentation